Filing Details
- Accession Number:
- 0001181431-12-015342
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-03-07 19:36:47
- Reporting Period:
- 2012-03-05
- Filing Date:
- 2012-03-07
- Accepted Time:
- 2012-03-07 19:36:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1325879 | Aveo Pharmaceuticals Inc | AVEO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1486359 | Jeno Gyuris | C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139 | Svp, Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-05-05 | 3,000 | $13.17 | 83,512 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-03-07 | 2,000 | $13.00 | 81,512 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $13.15 to $13.20 per share. The reporting person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.